MSCA-Marie Sklodowska-Curie Actions (MSCA)
Determining Genetic Bases of Differential Response to Antipsychotics Using Patient-Derived Neurons
Schizophrenia (SCZ) affects 20 million people worldwide and antipsychotics remain the only effective pharmacological intervention. However, one-third of people with SCZ do not respond to first-line antipsychotic drugs. In the absence of clinical biomarkers to stratify SCZ subtypes, all individual...